Gavin Cloherty

Direct and Catalytic C ‐Glycosylation of Arenes: Expeditious Synthesis of the Remdesivir Nucleoside**

Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies

Modelling hepatitis C therapy—predicting effects of treatment

Immiscible Phase Nucleic Acid Purification Eliminates PCR Inhibitors with a Single Pass of Paramagnetic Particles through a Hydrophobic Liquid

Equine pegiviruses cause persistent infection of bone marrow and are not associated with hepatitis

Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir

A global view of hepatocellular carcinoma: trends, risk, prevention and management

Hepatitis Viruses in Kidney Transplantation

A nonfluorescent, broad-range quencher dye for Förster resonance energy transfer assays

Treatment of hepatitis C in difficult-to-treat patients

The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation

Comparison of Two Commercial Automated Nucleic Acid Extraction and Integrated Quantitation Real-Time PCR Platforms for the Detection of Cytomegalovirus in Plasma

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

Sexually Transmitted Infections Treatment Guidelines, 2021

PCR inhibitors - occurrence, properties and removal

First description of Theiler's disease‐associated virus infection and epidemiological investigation of equine pegivirus and equine hepacivirus coinfection in Brazil

Rapid and Sensitive Detection of Antigen from SARS-CoV-2 Variants of Concern by a Multivalent Minibinder-Functionalized Nanomechanical Sensor

Gold Nanoparticles in Chemical and Biological Sensing

Cyanoamidine Cyclization Approach to Remdesivir’s Nucleobase

Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy

Sexually transmitted hepatitis C virus infections: current trends, and recent advances in understanding the spread in men who have sex with men

EASL Recommendations on Treatment of Hepatitis C 2018

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Analytical Sensitivity of the Abbott BinaxNOW COVID-19 Ag Card

Global Elimination of Chronic Hepatitis

Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection

Binary Probes for Nucleic Acid Analysis

HCV RNA Assay Sensitivity Impacts the Management of Patients Treated with Direct-Acting Antivirals

Evaluation of a Hepatitis C Virus Core Antigen Assay in Plasma and Dried Blood Spot Samples

Thermodynamically modulated partially double-stranded linear DNA probe design for homogeneous real-time PCR

Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse

Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performance

HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies

Importance of very early HCV RNA kinetics for prediction of treatment outcome of highly effective all oral direct acting antiviral combination therapy

Role of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus Infection

Sequence Conservation of the Region Targeted by the Abbott RealTi m e HCV Viral Load Assay

Clinical Utility of HCV Core Antigen Detection and Quantification in the Diagnosis and Management of Patients with Chronic Hepatitis C Receiving an All-Oral, Interferon-Free Regimen